Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2003
05/15/2003US20030092147 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092133 Interleukins-21 and 22
05/15/2003US20030092132 Fusion protein for use as diagnostic tool in genetic engineering
05/15/2003US20030092130 DNA encoding polypeptides having interferon-gamma inducing activity
05/15/2003US20030092129 Nervous system polypeptide for use in the treatment of nervous system disorders
05/15/2003US20030092122 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092121 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092120 Novel human K+ ion channel and therapeutic applications thereof
05/15/2003US20030092115 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092113 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092112 Novel nucleic acids and polypeptides
05/15/2003US20030092111 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092108 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092107 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092106 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092105 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092104 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092103 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092102 Nucleic acids, proteins, and antibodies
05/15/2003US20030092094 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
05/15/2003US20030092088 Kit for use in the classification of mammalian blood
05/15/2003US20030092085 Antibody against glyceraldehyde-3-phosphate dehydrogenase and use thereof
05/15/2003US20030092084 EBV-infected stomach cancer cell line
05/15/2003US20030092073 Method for sequence specific biotinylation
05/15/2003US20030092069 Hollow nanoparticle for use in the transfer of biopolymer into cells
05/15/2003US20030092065 Peptide for use in the treatment and prevention of allergies
05/15/2003US20030092061 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferation and tumor disorders
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092057 Detection of ligands for preferential polypeptides; obtain sample, incubate with ligand sample, detect bound ligand
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030092043 Melanoma differentiation associated gene - 5 and promoter and uses thereof
05/15/2003US20030092033 Methods for the Manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes
05/15/2003US20030092031 Methods for the detection, analysis and isolation of nascent proteins
05/15/2003US20030092025 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment, prevention of tumor disorders
05/15/2003US20030092024 Essential bacterial genes and their use
05/15/2003US20030092011 Human cDNAs and proteins and uses thereof
05/15/2003US20030092006 Classification of preferential nucleotide sequences; obtain nucleotide sequences, insert into vector, transform cells, generate clones, generate ribonucleic acid from clones, divide sequences, amplify and measure sequence concentration
05/15/2003US20030092002 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030091995 Generation of human antibody display library; obtain trangenic animal, transform with nucleotide sequence which code antibodies, form library of display packages displaying antibody chains
05/15/2003US20030091976 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
05/15/2003US20030091582 Autoimmune diseases; antitumor agents; antiallergens
05/15/2003US20030091575 Activation immunology response; administering fusion protein
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091566 Antitumor agents
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091561 Anticancer agents
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466595A1 Protein knobs
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466128A1 Antibodies to cd40
05/15/2003CA2466049A1 Human monoclonal antibodies to dendritic cells
05/15/2003CA2465951A1 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003CA2465950A1 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
05/15/2003CA2465828A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
05/15/2003CA2465724A1 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
05/15/2003CA2465679A1 High level constitutive production of anthrax protective antigen
05/15/2003CA2465476A1 Methods and compositions for correction of cardiac conduction disturbances
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2464470A1 Novel epidermal growth factor protein and gene, and methods of use therefor
05/15/2003CA2463855A1 Weed controller metabolism proteins, genes thereof and use of the same
05/15/2003CA2462462A1 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/14/2003EP1310798A2 Cell tests and diagnostic index for Alzheimer's disease
05/14/2003EP1310795A1 Chemical sensor and method of detecting chemical
05/14/2003EP1310560A1 Method of modifying microorganism-origin transglutaminase
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310557A1 Design of bioactive peptides based on immunoglobulin structure
05/14/2003EP1310554A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
05/14/2003EP1310510A2 Topologically segregated, encoded solid phase libraries
05/14/2003EP1309869A1 Designing and screening random libraries of compounds
05/14/2003EP1309861A1 Functional protein arrays
05/14/2003EP1309716A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
05/14/2003EP1309705A2 Multivalent target binding protein
05/14/2003EP1309700A2 Human phosphodiesterases
05/14/2003EP1309694A2 Method for improved production of cyanophycin and the secondary products thereof
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309692A2 Anti-il-12 antibodies, compositions, methods and uses
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
05/14/2003EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309682A2 Tetraspan protein and uses thereof
05/14/2003EP1309680A2 Dna & protein binding miniature proteins
05/14/2003EP1309679A2 Human genes and gene expression products
05/14/2003EP1309675A2 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309604A2 Phage-dependent superproduction of biologically active protein and peptides
05/14/2003EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
05/14/2003EP1309340A1 High mannose proteins and methods of making high mannose proteins
05/14/2003EP1309336A1 Derivatives of laspartomycin and preparation and use thereof
05/14/2003EP1267940B1 Compounds for targeting
05/14/2003EP1246631B1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures
05/14/2003EP0991946B1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor
05/14/2003EP0868427B1 Methods for identifying compounds that bind to a target
05/14/2003EP0814838B1 Antigen presenting system and activation of t-cells
05/14/2003EP0813541B1 Process for producing a protein
05/14/2003EP0753065B1 Antibodies against e-selectin